surmount 5 tirzepatide SURMOUNT-5 (NCT05822830) was a multi-center, randomized, open-label, phase 3b trial evaluating the efficacy and safety of #Zepbound® (tirzepatide) compared with #Wegovy® (semaglutide, similar to full dose #ozempic) in adults with obesity + Tirzepatide Tops Semaglutide for Weight
Pay in 4 interest-free payments of $5.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7











:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)

/assets/images/provider/photos/2745153.jpeg)













